SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1232395
NEW YORK, NY
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,597,983
+$546,056 QoQ
Shares Held
45,668
-4.7% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#98
of 343 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $128,449,389 across 20 Biotechnology names. PTGX ranks #13 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
896,651 | $39,892,002 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
77,278 | $9,046,935 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
103,616 | $8,445,740 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
15,655 | $8,405,952 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
73,432 | $8,153,154 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,346 | $8,119,548 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
159,545 | $6,174,391 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
39,865 | $6,092,169 |
All Filings in PTGX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,597,983 | 45,668 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,051,927 | 47,931 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,647,972 | 53,217 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,535,205 | 53,217 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,024,540 | 54,723 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,646,404 | 54,723 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,258,843 | 84,426 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,836,430 | 85,254 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,623,971 | 191,168 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $5,460,334 | 188,743 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,138,773 | 180,496 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,010,106 | 180,462 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,540,801 | 128,197 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,607,165 | 113,355 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,626,527 | 240,745 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,048,599 | 243,013 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $907,743 | 114,759 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,837,669 | 119,834 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,060,053 | 118,715 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,264,197 | 71,343 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,358,268 | 119,391 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||